Breast Cancer Treatment in Azerbaijan 2026 — Herceptin, Enhertu, Ibrance

    HER2+, HR+/HER2-, TNBC, BRCA+ breast cancer — full regimen supplied to Baku and 9 cities. Cold-chain from Turkey.

    📱 WhatsApp Consultation

    Pharmacy Remedy supplies the entire breast cancer treatment spectrum to Azerbaijan: HER2-targeted (Herceptin, Perjeta, Enhertu), CDK4/6 inhibitors for HR+/HER2- (Ibrance), PARP inhibitors for BRCA mutations (Lynparza), and ADCs for triple-negative disease (Trodelvy). All drugs are genuine, Turkey-sourced, with cold-chain delivery 2-5 days to clinic.

    Standard Regimens

    • HER2+ early: Herceptin + Perjeta + chemo (THP), 1 year adjuvant Herceptin
    • HER2+ metastatic 2L: Enhertu 5.4 mg/kg Q3W
    • HR+/HER2- metastatic: Ibrance 125mg + letrozole/fulvestrant
    • BRCA+ HER2- metastatic: Lynparza 300mg BID
    • Triple-negative metastatic 2L+: Trodelvy 10 mg/kg D1,D8 Q3W